JP2011190199A5 - - Google Patents

Download PDF

Info

Publication number
JP2011190199A5
JP2011190199A5 JP2010056428A JP2010056428A JP2011190199A5 JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5 JP 2010056428 A JP2010056428 A JP 2010056428A JP 2010056428 A JP2010056428 A JP 2010056428A JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5
Authority
JP
Japan
Prior art keywords
rheumatoid arthritis
administration
administered
bed
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010056428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011190199A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010056428A priority Critical patent/JP2011190199A/ja
Priority claimed from JP2010056428A external-priority patent/JP2011190199A/ja
Priority to PCT/JP2010/007262 priority patent/WO2011111143A1/ja
Publication of JP2011190199A publication Critical patent/JP2011190199A/ja
Publication of JP2011190199A5 publication Critical patent/JP2011190199A5/ja
Pending legal-status Critical Current

Links

JP2010056428A 2010-03-12 2010-03-12 関節リウマチ薬 Pending JP2011190199A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2010056428A JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬
PCT/JP2010/007262 WO2011111143A1 (ja) 2010-03-12 2010-12-15 関節リウマチ薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010056428A JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬

Publications (2)

Publication Number Publication Date
JP2011190199A JP2011190199A (ja) 2011-09-29
JP2011190199A5 true JP2011190199A5 (de) 2013-04-25

Family

ID=44562991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010056428A Pending JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬

Country Status (2)

Country Link
JP (1) JP2011190199A (de)
WO (1) WO2011111143A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
WO2016201044A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Osmotic burst encapsulates
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
WO2018183662A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Delayed release enzyme formulations for bleach-containing detergents
JP2020527339A (ja) 2017-06-30 2020-09-10 ダニスコ・ユーエス・インク 低凝集の酵素含有粒子
US20210222148A1 (en) 2017-12-21 2021-07-22 Danisco Us Inc. Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant
MX2020008302A (es) 2018-02-08 2020-10-14 Danisco Us Inc Partículas de matriz de cera térmicamente resistentes para encapsulación de enzimas.
WO2020047215A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Enzyme-containing granules
JP7546599B2 (ja) * 2019-05-10 2024-09-06 シナクト ファーマ エーピーエス 関節炎性疾患の組み合わせ療法
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules

Similar Documents

Publication Publication Date Title
JP2011190199A5 (de)
JP2015057451A5 (de)
JP2010503695A5 (de)
JP2017506624A5 (de)
JP2015523407A5 (de)
JP2015522630A5 (de)
JP2013541583A5 (de)
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
JP2013209384A5 (de)
JP2015532296A5 (de)
JP2016505050A5 (de)
MX2015009546A (es) Dosificacion aumentada de efavirenz para el tratamiento de cancer.
JP2012505830A5 (de)
HRP20161796T1 (hr) Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice
JP2017061488A5 (de)
SA516370446B1 (ar) تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها
JP2015509934A5 (de)
JP2017530142A5 (de)
JP2017511307A5 (de)
JP2017531042A5 (de)
HRP20220701T1 (hr) Spojeni benzazepini za liječenje touretteova sindroma
HRP20160811T1 (hr) Upotreba odiparcila u liječenju mukopolisaharidoze
JP2017515849A5 (de)
JP2015120650A5 (de)
Flanders et al. PHARMACOKINETICS OF SINGLE DOSE INTRAVENOUS AND ORAL FLUNIXIN MEGLUMINE IN THE BLACK RHINOCEROS (DICEROS BICORNIS)